Legal Representation
Attorney
Marc T. Morley
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 9, 2012 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 8, 2012 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Mar 15, 2012 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 14, 2012 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Mar 7, 2012 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Mar 7, 2012 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 14, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 13, 2011 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Sep 7, 2011 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Sep 7, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 10, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 9, 2011 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Mar 1, 2011 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 1, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 16, 2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 15, 2010 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 7, 2010 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 7, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 9, 2010 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 8, 2010 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 8, 2010 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 8, 2010 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Mar 8, 2010 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Apr 8, 2010 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 8, 2010 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 8, 2010 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Sep 8, 2009 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 16, 2009 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 27, 2009 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| May 12, 2009 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| May 8, 2009 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 7, 2009 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 7, 2009 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 7, 2009 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 7, 2009 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 18, 2008 | DMCC | I | DATA MODIFICATION COMPLETED | Loading... |
| Nov 18, 2008 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Nov 18, 2008 | GPRA | O | PRIORITY ACTION E-MAILED | Loading... |
| Nov 18, 2008 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Nov 13, 2008 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 12, 2008 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 12, 2008 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 14, 2008 | CEPE | I | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | Loading... |
| May 14, 2008 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 14, 2008 | GEAN | O | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| May 14, 2008 | GEAP | F | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| May 14, 2008 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | Loading... |
| May 7, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 7, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 5, 2008 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of allergy, Alzheimer's disease, asthma, autoimmune diseases and disorders, cardiovascular diseases and disorders, central nervous system and neurological diseases and disorders, erectile and sexual dysfunction and disorders, gastrointestinal diseases and disorders, gynecological and fertility diseases and disorders, hemolytic diseases and disorders, hormonal diseases and disorders, hypertension, infectious diseases, immunological, bacterial, viral and fungal diseases and disorders, inflammation and inflammatory diseases and disorders, migraines, musculoskeletal diseases and disorders, obesity, ophthalmic and eye diseases and disorders, osteoporosis, pain, Parkinson's disease, psychiatric diseases and disorders, respiratory diseases and disorders, smoking and substance addictions and related diseases and disorders, stroke, urological disorders, weight and appetite control
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of two curved lines intersecting to form an "X" with a solid circle above the intersecting point.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005